Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 2/20 | 0.33 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TOP1 | P11387 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22148529 | 0.91 | TOP1 (0.40) | KDM4ETOP1TSHRKMT2AMEN1 | |
| SCHEMBL30709517 | 0.89 | TOP1 (0.38) | PIK3CAABCG2TOP1TSHRADORA2A | |
| SCHEMBL22148545 | 0.88 | TSHR (0.36) | ABCG2KDM4ETSHRADORA3ALOX15 | |
| SCHEMBL30709549 | 0.86 | ABCG2 (0.35) | PIK3CAABCG2TOP1KMT2AMEN1 | |
| SCHEMBL30709398 | 0.84 | MEN1 (0.35) | KDM4ETOP1KMT2AMEN1ALDH1A1 | |
| SCHEMBL30709385 | 0.84 | TOP1 (0.40) | KDM4ETOP1TSHRALDH1A1 | |
| SCHEMBL21562840 | 0.84 | KMT2A (0.35) | KDM4ETOP1TSHRKMT2AMEN1 | |
| SCHEMBL22148726 | 0.84 | TOP1 (0.34) | TOP1TSHR | |
| SCHEMBL30709686 | 0.84 | MAPK14 (0.40) | KDM4EKMT2AMEN1ALDH1A1 | |
| SCHEMBL29996466 | 0.83 | ABCG2 (0.38) | PIK3CAABCG2TOP1TSHRKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | KYULUX, INC. (JP) | 2023-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11849634-B2 | Composition of matter for use in organic light- emitting diodes | NDUFV3, NDUFV2, CRY2 | PIK3CA 2934/4885ABCG2 145/4885KDM4E 4409/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.